Transplantation and surgical strategies in patients with neuroendocrine liver metastases: protocol of four systematic reviews. (Q35074937)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Transplantation and surgical strategies in patients with neuroendocrine liver metastases: protocol of four systematic reviews (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Reto Stump

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Silvia Haueis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Nicola Kalt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Christoph Tschuor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Dimitri A Raptis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Milo A Puhan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Stefan Breitenstein

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

23 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

published in

JMIR research protocols

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

e58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: a single centre experience

3 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Current knowledge on diagnosis and staging of neuroendocrine tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Multimodal management of neuroendocrine liver metastases.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

The blood supply of neoplasms in the liver

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

A 5-decade analysis of 13,715 carcinoid tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Karnofsky memorial lecture. An odyssey in the land of small tumors.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

8 July 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Endocrine tumors of the ileum: factors correlated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Radiofrequency ablation of neuroendocrine liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Hepatic neuroendocrine metastases: does intervention alter outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Multidisciplinary approach for the treatment of neuroendocrine tumors

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3875902

Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas

27 September 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.2196%2FRESPROT.2891

Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24366112

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Liver transplantation for neuroendocrine tumors: progress and uncertainty

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24366112

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24366112

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2196/RESPROT.2891

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366112%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference